American Well (AMWL) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
6 May, 2026Executive summary
Q1 2026 revenue was $54.9 million, down 18% year-over-year, driven by lower subscription revenue but partially offset by higher visit revenue; net loss narrowed to $10.3 million, reflecting cost reductions and strategic transformation actions.
Adjusted EBITDA improved to $(3.1) million from $(12.2) million in Q1 2025, and operational efficiency increased through headcount reductions and lease abandonment.
Renewed major contracts (Elevance, DHA), expanded government deployments, and achieved significant pipeline growth, with platform consolidation and AI-powered innovations driving customer renewals.
Maintained a strong cash position of $179.2 million at quarter end, with no debt and significantly reduced cash burn.
Positioned for cash flow breakeven in Q4 2026 and confident in multi-year growth.
Financial highlights
Subscription revenue was $24.9 million, down 23% year-over-year; AMG visit revenue was $28.9 million, up 9% year-over-year; total visits reached 1.1 million.
Gross profit was $28 million with a gross margin of 51%; operating expenses were $45.4 million, down 31% year-over-year.
Adjusted EBITDA loss was $3.1 million, improved from $12.2 million loss in Q1 2025; net loss per share was $(0.66), compared to $(1.19) in Q1 2025.
Cash and cash equivalents at quarter-end were $179.2 million, with cash burn reduced to $1.0 million from $25.1 million in Q1 2025.
Outlook and guidance
Q2 2026 revenue expected at $48–$52 million; adjusted EBITDA loss projected between $(4) million and $(2) million.
Full-year 2026 revenue guidance reaffirmed at $195–$205 million; adjusted EBITDA loss expected between $(16) million and $(12) million.
Targeting positive cash flow from operations in Q4 2026 and meaningful revenue growth in 2027.
Management expects continued operating losses in the near term but believes existing cash is sufficient for at least the next 12 months.
Latest events from American Well
- Key votes include director elections, auditor ratification, and executive pay approval.AMWL
Proxy filing23 Apr 2026 - 2025 saw major cost reductions, platform innovation, and strong governance ahead of key shareholder votes.AMWL
Proxy filing23 Apr 2026 - 2026 guidance targets $195–$205M revenue, EBITDA breakeven, and strong government contract momentum.AMWL
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Margins improved and losses narrowed, with positive cash flow targeted for Q4 2026.AMWL
Q4 202512 Feb 2026 - Director elections, auditor ratification, and reverse stock split proposal advanced to vote.AMWL
AGM 20243 Feb 2026 - Q2 revenue rose to $62.8M, losses narrowed, and 2024 EBITDA guidance improved.AMWL
Q2 20242 Feb 2026 - Converge platform drives digital-first care, boosting margins and setting up profitability by 2026.AMWL
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Q3 revenue was $61M, net loss narrowed, and cost actions support 2026 cash flow goals.AMWL
Q3 202417 Jan 2026 - Subscription revenue growth and DHA contract expansion drive confidence in 2026 profitability.AMWL
UBS Global Healthcare Conference14 Jan 2026